ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685459; 2) Community: the network communities that were significantly associated with the response to NSC 685459; 3) Molecule: the relationships between components within communities and NSC 685459; 4) MDR: the compounds that were significantly associated with the NSC 685459.

NSC Compound Enrichment Correlation
NSC 701748 Null 0.0123744972338278 0.54854874
NSC 703318 Null 0.0123744972338278 0.22630751
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0123744972338278 0.5213906
NSC 757948 (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-methoxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0123744972338278 -0.21016558
NSC 109084 Null 0.0123744972338279 0.24361142
NSC 117281 ANTINEOPLASTIC-117281 0.0123744972338279 0.24592146
NSC 622282 4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- 0.0123744972338279 0.14514576
NSC 627744 Null 0.0123744972338279 0.24183048
NSC 635922 Null 0.0123744972338279 0.36531093
NSC 645317 Sanguilutine pseudobase 0.0123744972338279 0.36957766
Total:106  Current:39    [First] [Prev] [Next] [Last]